Law Offices of Howard G. Smith reminds investors of the upcoming April 7, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased GSK plc. ("GSK" or the ...

You can also contact the Law Offices of Frank R. Cruz to discuss your legal rights by email at [email protected], by telephone at (310) 914-5007, or visit our website at www.frankcruzlaw.com .

GSK PLC closed 20.84% below its 52-week high of £18.24, which the company achieved on May 16th.

GSK announced several transactions involving the vesting and sale of ordinary shares under its Performance Share Plan and Deferred Investment Award Programme. The transactions involve key executives, ...

When drug companies manipulate the system to increase profits, patients suffer. Arizona Attorney General Kris Mayes is right ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

GSK, a British drugmaker, recently beat Q4 earnings estimates. The company is our FDI of the Month January 2025.

This strategy enables Pfizer to maintain a strong foothold in the generic drug market while also protecting its revenue ...

Vertex Pharmaceuticals Inc. will soon lose a member of its leadership team that helped the company achieve major revenue ...

The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...